Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ·Healthcare·Biotechnology
$84.00
-1.41%
Mkt Cap $5.82B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $56.21M | $57.25M | +1.86% | -$0.79 | -$0.73 | +7.59% | — | — |
| Q4 2025 Nov 4, 2025 | $55.98M | $51.30M | -8.36% | -$0.72 | -$0.82 | -13.89% | — | — |
| Q3 2025 Aug 5, 2025 | $51.33M | $48.50M | -5.51% | -$0.66 | -$0.75 | -13.64% | — | — |
| Q2 2025 May 7, 2025 | $43.28M | $32.70M | -24.44% | -$0.69 | -$0.81 | -17.39% | — | — |
| Q1 2025 Feb 26, 2025 | $38.48M | $41.83M | +8.69% | -$0.69 | -$0.72 | -4.35% | — | — |
| Q4 2024 Nov 5, 2024 | $35.93M | $33.25M | -7.45% | -$0.80 | -$0.73 | +8.75% | — | — |
| Q3 2024 Aug 6, 2024 | $28.79M | $29.08M | +1.00% | -$0.70 | -$0.55 | +21.43% | — | — |
| Q2 2024 May 7, 2024 | $28.79M | $25.97M | -9.81% | -$2.34 | -$2.35 | -0.43% | — | — |
| Q1 2024 Feb 22, 2024 | $25.38M | $24.23M | -4.52% | -$0.70 | -$0.70 | +0.00% | — | — |
| Q4 2023 Nov 7, 2023 | $26.35M | $22.50M | -14.60% | -$0.76 | -$0.76 | +0.00% | — | — |
| Q3 2023 Aug 1, 2023 | $22.96M | $19.22M | -16.28% | -$0.80 | -$0.82 | -2.50% | — | — |
| Q2 2023 May 2, 2023 | $12.12M | $11.47M | -5.37% | -$0.71 | -$0.92 | -29.58% | — | — |
| Q1 2023 Mar 1, 2023 | $7.22M | $8.79M | +21.77% | -$0.82 | -$0.75 | +8.54% | — | — |
| Q4 2022 Nov 8, 2022 | $4.76M | $4.28M | -10.02% | -$1.01 | -$0.79 | +21.78% | — | — |
| Q3 2022 Aug 2, 2022 | $2.57M | $9.07M | +253.38% | -$0.79 | -$0.89 | -12.66% | — | — |
| Q2 2022 May 3, 2022 | $2.30M | $1.50M | -34.87% | -$0.98 | -$1.05 | -7.14% | — | — |
| Q1 2022 Mar 1, 2022 | $1.70M | $1.82M | +6.75% | -$1.00 | -$0.85 | +15.00% | — | — |
| Q4 2021 Nov 2, 2021 | $940.00K | $1.03M | +9.36% | -$0.84 | -$0.70 | +16.67% | — | — |
| Q3 2021 Aug 3, 2021 | $274.00K | $274.00K | +0.00% | -$0.75 | -$0.70 | +6.67% | — | — |
| Q2 2021 May 3, 2021 | $35.00K | $35.00K | +0.00% | -$0.23 | $0.90 | +492.23% | — | — |